 |
InterPro: IPR001555 Phosphoribosylglycinamide formyltransferase, active site
Protein matches
|
UniProtKB Matches: 2072 proteins |
|
Accession
|
IPR001555 GART_AS |
Type
|
Active_site |
Signatures
|
|
InterPro Relationships
|
|
Found in
|
IPR002376 Formyl transferase, N-terminal
IPR004607 Phosphoribosylglycinamide formyltransferase
IPR005794 Methionyl-tRNA formyltransferase
IPR011407 10-formyltetrahydrofolate dehydrogenase
IPR015518 Methionine tRNA Formyltransferase-like
|
GO Term annotation
|
|
Function
|
GO:0008168 methyltransferase activity
|
|
InterPro annotation
|
|
Entry Details in BioMart
|
Abstract
|
Phosphoribosylglycinamide formyltransferase (EC:2.1.2.2) (GART) [1] catalyses the third step in de novo purine biosynthesis, the transfer of a formyl group to 5'-phosphoribosylglycinamide. In higher eukaryotes, GART is part of a multifunctional enzyme polypeptide that catalyses three of the steps of purine biosynthesis. In bacteria, plants and yeast, GART is a monofunctional protein of about 200 amino-acid residues.
In the Escherichia coli enzyme, an aspartic acid residue has been shown to be involved in the catalytic mechanism. The region around this active site residue is well conserved in GART from prokaryotic and eukaryotic sources.
Mammalian formyltetrahydrofolate dehydrogenase (EC:1.5.1.6) [2] is a cytosolic enzyme responsible for the NADP-dependent decarboxylative reduction of 10-formyltetrahydrofolate into tetrahydrofolate. It is a protein of about 900 amino acids consisting of three domains; the N-terminal domain (200 residues) is structurally related to GARTs.
E. coli methionyl-tRNA formyltransferase (EC:2.1.2.9) (gene fmt) [3] is the enzyme responsible for modifying the free amino group of the aminoacyl moiety of methionyl-tRMA(fMet). The central part of fmt seems to be evolutionary related to GART's active site region.
This signature contains the Asp active site residue.
|
Structural links
|
|
Database links
|
|
Example proteins
|
O75891 10-formyltetrahydrofolate dehydrogenase
P00967 Trifunctional purine biosynthetic protein adenosine-3
P04161 Phosphoribosylglycinamide formyltransferase
P52422 Phosphoribosylglycinamide formyltransferase, chloroplastic
Q64737 Trifunctional purine biosynthetic protein adenosine-3
More proteins
Example Proteins Key
| InterPro entry accession number/name and structure databases |
Colour code |
| IPR002376 |
Formyl transferase, N-terminal |
 |
| IPR011761 |
ATP-grasp fold |
 |
| IPR001555 |
Phosphoribosylglycinamide formyltransferase, active site |
 |
| IPR011034 |
Formyl transferase, C-terminal-like |
 |
| IPR010918 |
AIR synthase related protein, C-terminal |
 |
| IPR004733 |
Phosphoribosylformylglycinamidine cyclo-ligase |
 |
| IPR011054 |
Rudiment single hybrid motif |
 |
| IPR020561 |
Phosphoribosylglycinamide synthetase, ATP-grasp (A) domain |
 |
| IPR020560 |
Phosphoribosylglycinamide synthetase, C-domain |
 |
| IPR009081 |
Acyl carrier protein-like |
 |
| IPR020562 |
Phosphoribosylglycinamide synthetase, N-domain |
 |
| IPR000115 |
Phosphoribosylglycinamide synthetase |
 |
| IPR011407 |
10-formyltetrahydrofolate dehydrogenase |
 |
| IPR013815 |
ATP-grasp fold, subdomain 1 |
 |
| IPR013816 |
ATP-grasp fold, subdomain 2 |
 |
| IPR013817 |
Pre-ATP-grasp fold |
 |
| IPR020559 |
Phosphoribosylglycinamide synthetase, conserved site |
 |
| IPR004607 |
Phosphoribosylglycinamide formyltransferase |
 |
| IPR005793 |
Formyl transferase, C-terminal |
 |
| IPR016188 |
PurM, N-terminal-like |
 |
| IPR016162 |
Aldehyde dehydrogenase, N-terminal |
 |
| IPR016161 |
Aldehyde/histidinol dehydrogenase |
 |
| IPR016160 |
Aldehyde dehydrogenase, conserved site |
 |
| IPR016185 |
PreATP-grasp-like fold |
 |
| IPR015590 |
Aldehyde dehydrogenase |
 |
| IPR000728 |
AIR synthase related protein |
 |
|
ModBase |
 |
|
SWISS-MODEL |
 |
|
PDB Chain |
 |
|
CATH Domain |
 |
|
SCOP Domain |
 |
|
Additional Reading
|
|
Dahms TE, Sainz G, Giroux EL, Caperelli CA, Smith JL.
The apo and ternary complex structures of a chemotherapeutic target: human glycinamide ribonucleotide transformylase.
Biochemistry 44 2005 9841-50
[PubMed: 16026156]
http://dx.doi.org/10.1021/bi050307g
|
|
Kursula P, Schuler H, Flodin S, Nilsson-Ehle P, Ogg DJ, Savitsky P, Nordlund P, Stenmark P.
Structures of the hydrolase domain of human 10-formyltetrahydrofolate dehydrogenase and its complex with a substrate analogue.
Acta Crystallogr. D Biol. Crystallogr. 62 2006 1294-9
[PubMed: 17057331]
http://dx.doi.org/10.1107/S0907444906026849
|
|
Chumanevich AA, Krupenko SA, Davies C.
The crystal structure of the hydrolase domain of 10-formyltetrahydrofolate dehydrogenase: mechanism of hydrolysis and its interplay with the dehydrogenase domain.
J. Biol. Chem. 279 2004 14355-64
[PubMed: 14729668]
http://dx.doi.org/10.1074/jbc.M313934200
|
|
Zhang Y, Desharnais J, Greasley SE, Beardsley GP, Boger DL, Wilson IA.
Crystal structures of human GAR Tfase at low and high pH and with substrate beta-GAR.
Biochemistry 41 2002 14206-15
[PubMed: 12450384]
http://dx.doi.org/10.1021/bi020522m
|
|
Zhang Y, Desharnais J, Marsilje TH, Li C, Hedrick MP, Gooljarsingh LT, Tavassoli A, Benkovic SJ, Olson AJ, Boger DL, Wilson IA.
Rational design, synthesis, evaluation, and crystal structure of a potent inhibitor of human GAR Tfase: 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic acid.
Biochemistry 42 2003 6043-56
[PubMed: 12755606]
http://dx.doi.org/10.1021/bi034219c
|
|
|
InterPro 23.1
|